NCT00608517 · OUTCOME

Overall Survival

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil · Source last updated 2014-05-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: 1 year

What was measured

Overall survival at 1 year

Groups in this outcome

Pediatric Myeloablative Conditioning

Patients undergo total-body irradiation on days -7 to -4, and receive cyclophosphamide intravenous (IV) over 1 hour on days -3 and -2, methylprednisolone IV twice daily on days -3 to -1, and anti-thymocyte globulin IV over 4 hours on days -3 to -1.

Adult Myeloablative Conditioning

Patients receive fludarabine phosphate intravenous (IV) over 30 minutes on days -6 to -4, cyclophosphamide IV over 1 hour on days -5 and -4, and undergo total-body irradiation on days -3 to -1.

Reduced-intensity Conditioning

Patients receive fludarabine phosphate intravenous (IV) over 30 minutes on days -6 to -2 and cyclophosphamide IV over 1 hour on day -6 and undergo total-body irradiation on day -1.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Pediatric Myeloablative Conditioning	2
Adult Myeloablative Conditioning	3
Reduced-intensity Conditioning	1

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Pediatric Myeloablative Conditioning	1	Not reported	Not reported	Not reported	Not reported
Adult Myeloablative Conditioning	3	Not reported	Not reported	Not reported	Not reported
Reduced-intensity Conditioning	1	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
1
group Id
OG001
value
3
group Id
OG002
value
1

denoms

counts
group Id
OG000
value
2
group Id
OG001
value
3
group Id
OG002
value
1
units
Participants

description

Overall survival at 1 year

groups

description
Patients undergo total-body irradiation on days -7 to -4, and receive cyclophosphamide intravenous (IV) over 1 hour on days -3 and -2, methylprednisolone IV twice daily on days -3 to -1, and anti-thymocyte globulin IV over 4 hours on days -3 to -1.
id
OG000
title
Pediatric Myeloablative Conditioning
description
Patients receive fludarabine phosphate intravenous (IV) over 30 minutes on days -6 to -4, cyclophosphamide IV over 1 hour on days -5 and -4, and undergo total-body irradiation on days -3 to -1.
id
OG001
title
Adult Myeloablative Conditioning
description
Patients receive fludarabine phosphate intravenous (IV) over 30 minutes on days -6 to -2 and cyclophosphamide IV over 1 hour on day -6 and undergo total-body irradiation on day -1.
id
OG002
title
Reduced-intensity Conditioning

param Type

NUMBER

reporting Status

POSTED

time Frame

1 year

title

Overall Survival

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice